HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

Nordic Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


Nordic Radiopharmaceutical Synthesizer Market Insights

  • As highlighted in Reed Intelligence analysis, the Nordic Radiopharmaceutical Synthesizer Market, worth USD 33.76 Million in 2024, is forecasted to achieve USD 51.73 Million by 2033.
  • The Nordic market is anticipated to grow at a CAGR of 4.81% during the period 2026–2033.
  • By 2024, PET represented the largest share of the Modality market size.
  • PET is expected to remain the key growth driver within Modality, registering the fastest CAGR during the forecast period.

Other Key Findings


  • As of 2024, Nordic held 1.08% of the global Radiopharmaceutical Synthesizer Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Radiopharmaceutical Synthesizer Market.
  • In Europe, Germany is expected to lead the regional Radiopharmaceutical Synthesizer Market size by 2033.
  • Russia will remain the fastest-growing market in Europe, reaching USD 82.43 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 33.76 Million
Market Size In 2033 USD 51.73 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.81% (2025-2033)
Segmnetation Covered
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports